Memantine And Donepezil Hydrochlorides Capsule, Extended Release
Product Images NDC 62559-207

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine And Donepezil Hydrochlorides (NDC 62559-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

21-10label (21 10label)

21-10label (21 10label)
This is a product description for Memantine and Donepezil hydrochlorides extended-release capsules. Each capsule contains 21 mg of memantine HCI and 10 mg of donepezil HCI. It is prescribed for once-daily use, with 30 capsules in a pack. It is important to store the medication at 20° to 25°C (68° to 77°F) and protect it from moisture. The medicine should be kept in a tight, light-resistant container, away from children's reach. Distributed by ANI Pharmaceuticals, Inc.*
FDA Label Image

Donepezil-structure (Donepezil Structure)

Donepezil-structure (Donepezil Structure)
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This text appears to provide information about a drug called Viamantns HCI ER 28mg. It mentions the change from baseline in a clinical trial, with results possibly related to improvement and decline. It also refers to a placebo. It seems to show data after 2 weeks of treatment, highlighting clinical improvements.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This is a table showing the percentage of patients with different levels of improvement when comparing Memantine HCI ER 28 mg to Placebo in terms of AChE. The levels of improvement range from marked improvement to worsening, with corresponding percentages of patients for each level. The table also includes the CIBIC-Plus Rating for the comparison.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
FDA Label Image

Figure-6 (Figure 6)

Figure-6 (Figure 6)
FDA Label Image

Figure-7 (Figure 7)

Figure-7 (Figure 7)
FDA Label Image

Figure-8 (Figure 8)

Figure-8 (Figure 8)
FDA Label Image

Memantine-structure (Memantine Structure)

Memantine-structure (Memantine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.